Endo International (ENDP) on Thursday reported adjusted profit of 71 cents per share on $745.5 million in sales. In the year-ago period, the generic pharmaceutical company earned 91 cents per share, excluding items, on $786.9 million in sales.




X



On average, analysts polled by Zacks Investment Research called for adjusted earnings of 59 cents a share on $697 million in sales.

For the year, Endo guided to adjusted earnings of $2.65-$2.75 a share on $2.87 billion to $2.92 billion in sales. Analysts had forecast adjusted income of $2.60 per share on $2.82 billion in sales.

In premarket trading on the stock market today, Endo stock rose 2.8%, near 16.50. Endo stock is highly rated by the standards of Investor’s Business Daily. It has a best-possible Relative Strength Rating of 99. The RS Rating tracks a stock’s performance over the past 12 months.

More to follow.

YOU MIGHT ALSO LIKE:

The Basics: How To Analyze A Stock’s Cup-With-Handle Base

IBD Stock Of The Day

How To Trade: Should You Buy A Stock Ahead Of Its Earnings Report?



READ SOURCE

LEAVE A REPLY

Please enter your comment!
Please enter your name here